Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RIZZO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.117
EU - Europa 3.027
AS - Asia 2.416
SA - Sud America 445
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 14.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.053
SG - Singapore 921
IT - Italia 813
CN - Cina 768
RU - Federazione Russa 428
FI - Finlandia 407
BR - Brasile 365
DE - Germania 345
HK - Hong Kong 217
UA - Ucraina 216
PL - Polonia 168
GB - Regno Unito 167
VN - Vietnam 135
IE - Irlanda 133
KR - Corea 82
SE - Svezia 68
FR - Francia 67
IN - India 64
NL - Olanda 47
BE - Belgio 46
TR - Turchia 35
RO - Romania 33
JP - Giappone 32
AT - Austria 30
CI - Costa d'Avorio 30
AR - Argentina 29
CA - Canada 29
IQ - Iraq 28
ES - Italia 26
BD - Bangladesh 22
MX - Messico 20
IR - Iran 19
UZ - Uzbekistan 17
ZA - Sudafrica 17
VE - Venezuela 13
MA - Marocco 11
ID - Indonesia 9
KE - Kenya 9
CO - Colombia 8
EC - Ecuador 8
DK - Danimarca 7
MY - Malesia 7
PK - Pakistan 7
IL - Israele 6
LB - Libano 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
CH - Svizzera 5
CL - Cile 5
EU - Europa 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
PH - Filippine 4
PY - Paraguay 4
TW - Taiwan 4
AL - Albania 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
MK - Macedonia 2
NO - Norvegia 2
QA - Qatar 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 14.094
Salva come PNG Salva come JPEG
Città #
Fairfield 1.351
Ashburn 1.000
Woodbridge 621
Chandler 530
Seattle 521
Singapore 504
Houston 482
Wilmington 469
Cambridge 405
Ann Arbor 391
Palermo 221
Hong Kong 217
Moscow 148
Zgierz 146
Beijing 133
Dublin 131
Medford 124
Des Moines 120
Jacksonville 106
Altamura 94
Nanjing 94
The Dalles 84
New York 82
Princeton 79
San Diego 78
Dallas 77
Lawrence 71
Los Angeles 71
Dearborn 66
Santa Clara 55
Hefei 52
Ho Chi Minh City 51
São Paulo 46
Boardman 45
Brussels 44
Seoul 42
Ludwigshafen am Rhein 41
London 39
Jinan 36
Buffalo 35
Council Bluffs 33
Phoenix 32
Tulsa 32
Seongnam 31
Shenyang 31
Tianjin 31
Abidjan 30
Hebei 28
Nanchang 28
Bremen 26
Chicago 26
Tokyo 25
Changsha 24
Milan 24
Hanoi 23
Frankfurt am Main 22
Helsinki 21
Kumar 21
Rome 21
Guangzhou 20
Nuremberg 19
Kitzingen 18
Munich 17
Warsaw 17
Denver 16
Izmir 16
Ningbo 16
Saint Petersburg 16
Berlin 15
Jiaxing 15
Orange 15
Amsterdam 14
Brooklyn 14
San Paolo di Civitate 14
Tehran 14
Columbus 13
Enschede 12
Montreal 12
Orem 12
Vienna 12
Atlanta 11
Baghdad 11
Belo Horizonte 11
Fuzhou 11
Pune 11
Stockholm 11
Zhengzhou 11
Kilburn 10
Ankara 9
Da Nang 9
Johannesburg 9
Redwood City 9
Venice 9
Chennai 8
Nairobi 8
Poplar 8
San Jose 8
Taiyuan 8
Verona 8
Washington 8
Totale 9.916
Salva come PNG Salva come JPEG
Nome #
EGFR inhibition in NSCLC: New findings…. and opened questions? 300
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 275
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 253
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 247
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 247
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 246
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 245
Anti-endothelin drugs in solid tumors 242
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 238
A headlight on liquid biopsies: a challenging tool for breast cancer management 237
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 236
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 234
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 233
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 232
Breast cancer genome-wide association studies: there is strength in numbers 229
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 228
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 228
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 226
Nintedanib in NSCLC: Evidence to date and place in therapy 226
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 224
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 223
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 219
EGFR genomic alterations in cancer: prognostic and predictive values 214
Monoclonal antibodies in gastrointestinal cancers 212
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 212
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 210
Male breast cancer. 208
Biomarkers and efficacy: Are we nearly there yet? 208
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 207
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) 202
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 201
HER2-positive male breast cancer: An update 197
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 196
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 196
Hereditary ovarian cancer 194
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 191
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 188
Gene signatures in CRC and liver metastasis 188
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 188
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 187
Sex steroids, carcinogenesis, and cancer progression 185
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 184
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 179
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 179
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 177
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 170
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 169
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? 168
New molecular targets in bone metastases 164
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 161
Bortezomib: a new pro-apoptotic agent in cancer treatment. 160
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 158
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients 156
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial. 155
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 155
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 155
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 154
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 153
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients 149
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer 147
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 143
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 143
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 142
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy. 141
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 138
Low dose splenic irradiation in myelofibrosis: outcomes and toxicity of three radiation schedule 137
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 137
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 134
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients 127
Could starvation minimize chemotherapy-induced toxicities? 126
Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness 124
Early stage nasal vestibule tumors: safety and efficacy of HDR brachyterapy in elderly patients 123
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway 122
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 121
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 117
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 109
La consulenza genetica in oncologia: implicazioni biomolecolari e cliniche. 106
"ONCOGENE ADDICTED SOLID TUMORS: BIOMARKERS PROGNOSTIC AND PREDICTIVE OF RESISTANCE OR SENSITIVITY TO MOLECULAR TARGETED THERAPIES IN CRC 98
null 69
Cardiovascular risk in patients without known cardiovascular disease 63
null 9
Totale 14.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.158
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021928 0 0 0 0 0 54 145 107 171 178 156 117
2021/20221.192 68 295 30 38 63 46 87 52 105 140 96 172
2022/20231.525 147 300 37 193 153 235 111 105 143 8 55 38
2023/2024632 31 84 50 42 37 114 73 78 2 15 12 94
2024/20251.615 31 108 97 128 56 68 166 153 88 166 204 350
2025/20262.712 472 173 308 448 579 732 0 0 0 0 0 0
Totale 14.574